This review summarizes our knowledge of analogs and derivatives of diadenosine 5¢,5¢¢¢-P 
heptaphosphates have been detected in some mammalian cells. In vitro studies suggest that the following enzymes from various phyla may be responsible for the accumulation of the adenine-containing Np n N¢ s in vivo: certain aminoacyl-tRNA synthetases (EC 6.1.1.x) , Ap 4 A phosphorylase (EC 2.7.7.53) (Guranowski et al., 1988) , firefly luciferase (EC 1.13.12.7) , acyl-CoA synthetase (EC 6.2.1.8) (Fontes et al., 1998) , HIV-1 reverse transcriptase (EC 2.7.7.49) (Meyer et al., 1998) , DNA ligases (EC 6.5.1.1) (Madrid et al., 1998; McLennan, 2000; Günther Sillero et al., 2002) , RNA ligase (EC 6.5.1.3) (Atencia et al., 1999) , nonribosomal peptide synthetase (Dieckman et al., 2001) and, in plants, coumarate-CoA synthetase (EC 6.2.1.12) (Pietrowska-Borek et al., 2003) . A GTP:GTP guanylyltransferase (EC 2.7.7.45) also exists in certain organisms and may be responsible for the synthesis of Gp n Ns, i.e. guanine-containing Np n N¢ s (Wang & Shatkin, 1984; Liu & McLennan, 1994) . These enzymes are particularly effective in the synthesis of dinucleoside tetraphosphates: diadenosine tetraphosphate (AppppA or Ap 4 A) and diguanosine tetraphosphate (GppppG or Gp 4 G), respectively. They are also able to synthesize Np n N¢ s in which n>4. Not all of them, however, can produce Np 3 N¢ s. For example, firefly luciferase and coumarate-CoA synthetase are incapable of Ap 3 A synthesis. Finally, it has been suggested ) that dinucleotides such as Ap 4 U and Ap 4 C, found among the pyrimidine-containing Np 4 N¢ s in Escherichia coli and Saccharomyces cerevisiae , can be formed by enzymatic transfer of UMP-and CMP-moieties onto ATP from appropriate intermediates involved in carbohydrate and lipid metabolism (e.g. UDP-glucose and CDP-choline, respectively). In fact, the uridine triphosphate:glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) from S. cerevisiae has been recently found to synthesize Up n Ns, including Ap 4 U and Ap 5 U, by transfer of the UMP residue from UDP-glucose on to ATP and p 4 A, respectively. (Guranowski et al., 2004) .
The biological roles of Np n N¢ s are rather obscure. Some data suggest that they act as signalling molecules in, for example, regulation of the cell cycle (Grummt, 1978; Nishimura, 1998) . Under certain circumstances, e.g. when competing with ATP in ATP-dependent reactions (Rotllan & Miras-Portugal, 1985; Pype & Slegers, 1993) and/or binding with nucleotide receptors , Np n N¢ s can be detrimental to the organism (McLennan, 2000) . The levels of Np n N¢ s can be precisely regulated by numerous degradative enzymes (Guranowski, 2000) . In addition to the non-specific ones, like nucleotide pyrophosphatases/phosphodiesterases Bartkiewicz et al., 1984; Cameselle et al., 1984; Gasmi et al., 1998; Vollmayer et al., 2003) , for which Np n N¢ s are very good substrates, there are various specific enzymes. In higher eukaryotes (animals and plants) there is a dinucleoside triphosphatase (EC 3.6.1.29) that preferentially converts Np 3 N¢ s to nucleoside mono-and diphosphates, NMP + N¢ DP and/or N¢ MP + NDP, and a dinucleoside tetraphosphatase (EC 3.6.1.17) that asymmetrically hydrolyzes Np 4 N¢ s to either NTP + N¢ MP or N¢ TP + NMP. In lower eukaryotes -fungi (yeast) and protozoa (Euglena) -dinucleoside tetraphosphates are degraded phosphorolytically, either to N¢ DP + NTP or to NDP + N¢ TP, by Ap 4 A phosphorylases (EC 2.7.7.53). In bacteria, Np 4 N's are hydrolyzed symmetrically to NDP + N¢ DP by a specific Co 2+ -dependent Ap 4 A hydrolase (EC 3.6.1.41). Recently, however, an asymmetrically-acting Np 4 N-ase related to the higher eukaryotic enzyme has been detected in several bacteria (Conyers & Bessman, 1999; Bessman et al., 2001; Lundin et al., 2003) . The asymmetrical Np 4 N-ases belong to the "nudix" protein family, comprising enzymes that hydrolyze nucleotides in which a nucleoside diphosphate is attached to one of various groups assigned as x (Bessman et al., 1996; . These nudix proteins have a conserved amino+acid sequence that directly participates in catalysis (Harris et al., 2000; Maksel et al., 2001) . A search for nudix proteins in various genomes has led to the discovery of hydrolases that prefer Ap 5 A and/or Ap 6 A as substrates in budding yeast (S. cerevisiae) , fission yeast (Schizosaccharomyces pombe) and humans (Safrany et al., 1999) . One approach to understanding the biological roles of Np n N¢ s is through the use of structural analogs in biochemical and physiological studies. This review focuses on analogs of diadenosine 5¢ ,5¢ ¢ ¢ -P 1 ,P 4 -tetraphosphate (1)* (Ap 4 A), the most widely investigated member of the Np n N¢ s, and presents our current knowledge of both chemically and enzymatically produced nucleotides. Particular attention is paid to compounds that have been useful in studies of enzymes involved in the metabolism of Ap 4 A. Analogs that behave either as alternative substrates of Ap 4 A-degrading enzymes and/or as enzyme inhibitors have helped to establish the mechanism of action of these enzymes. They have also increased the sensitivity of some enzyme assays, or, by forming stable enzyme:ligand complexes, allowed an analysis of the substrate-binding site in the three-dimensional structures of certain hydrolases. This work partially updates two earlier reviews (Blackburn et al., 1992; Guranowski, 2000) that presented some chemical and biological aspects of both Ap 4 A and Ap 3 A analogs.
CHEMICALLY SYNTHESIZED ANALOGS OF Ap 4 A
Organic chemists have produced a wide variety of Ap 4 A analogs differing from Ap 4 A either in the oligophosphate chain (thus being Ap 4 A homologs), in the base, and/or in the sugar moieties. Np n N¢ s, including Ap 4 A, were observed by John Moffatt and co-workers in 1965 as highly stable by-products of ATP dismutation reactions (Reiss & Moffatt, 1965) . Subsequently, procedures directed towards the syntheses of various homo-(N = N¢ ) and hetero-(N N¢ ) Np n N¢ s were developed in several laboratories (Feldhaus et al., 1975; Tarussova et al., 1986; Ng & Orgel, 1987; Fukuoka et al., 1995) . Other laboratories focused on syntheses that yielded analogs modified in the polyphosphate chain. These comprised: (i) replacement of the P 2 -P 3 (2), P 1 -P 2 (3) or P 1 -P 2 and P 3 ,P 4 (4) bridging oxygen(s) with methylene (2-4), halomethylene-(5), ethylene-or acetylene-group(s) (Tarussova et al., 1983; Blackburn et al., 1987a) ; (ii) replacement of the oxygen(s) with imido group(s) (Shumiyanzeva & Poletaev, 1984) ; (iii) attachment of adenylate moieties to methanetrisphosphonate (10) ; (iv) adenylylation of polyalcohols such as glycerol, erythritol (11) and pentaerythritol (Baraniak et al., 1999) and (v) adenylylation of the hydroxymethyl groups of di(hydroxymethyl)phosphinic acid (Baraniak et al., 1999 ). Yet another group of chemically generated Ap 4 A analogs comprised mono-(6-7) (Haikal et al., 1989; Puri et al., 1995) and diphosphorothioates either of Ap 4 A (8) (Blackburn et al., 1987b) , or of the aforementioned Ap 4 A analogs with methylene or halomethylene group(s) (9) (Blackburn & Guo, 1990) , or of the derivatives of polyols (12-14) (Baraniak et al., 1999) and di(hydroxymethyl)phosphinic acid (Baraniak et al., 1999; Walkowiak et al., 2002) . Recently, di(adenosine-5'-O-phosphorodithioate),di(hydroxymethyl)phosphonic acid (15) was synthesized (Walkowiak et al., 2002) . and eAp 4 eA (17) (Wierzchowski et al., 1985; Rotllán et al., 1991) . Periodate converts Ap 4 A into its (bis)2¢ ,3¢ -dialdehyde derivative, oAp 4 oA (25), which can serve as an affinity label (Grummt et al., 1979) . A chromogenic analog, in which 5-bromo-4-chloro-3-indolyl phosphate is coupled to ATP (19) (Garrison et al., 1993) , another fluorescent analog, lin-benzoAp 4 A (18) (VanDerLijn et al., 1979) , and two analogs for affinity labeling, 8-azido-Ap 4 A (20) (Prescott & McLennan, 1990; Baxi et al., 1994) and pyridoxal-p 4 A (21) (Yagami et al., 1988) , have also been synthesized. So far, only three Ap 4 A analogs modified in the sugar (ribose) moieties have been synthesized. These are the dinucleotides containing fluorescent N-methylanthraniloyl group(s) (abbreviated here as m) bound to the 2¢ -or 3¢ -hydroxyl of the ribose(s) via an ether linkage: mAp 5 A and mAp 5 mA (26) (Reinstein et al., 1990) and mAp 5 T (Lavie et al., 1998) .
ENZYMATICALLY PRODUCED Ap 4 A ANALOGS
Enzymatically produced Ap 4 A analogs can be synthesized as a result of the broad substrate specificity of some ligases, transferases and firefly luciferase. This ability is conferred principally by the adenylate-binding sites of these enzymes. Certain aminoacyl-tRNA synthetases Plateau & Blanquet, 1982; Jakubowski, 1983; Theoclitou et al., 1994) , yeast Ap 4 A phosphorylase Guranowski et al., 1988; £a¿ewska & Guranowski, 956 A. Guranowski 2003 Sillero et al., 1991) . Some sugar-modified NTPs such as dATP, ddATP and araATP have also been used as adenylate acceptors yielding dAppppA, ddAppppA and araAppppA (24) Plateau & Blanquet, 1982; Theoclitou et al., 1994; Günther Sillero et al., 1997) . It has been shown that dATP and ddATP, used as the sole NTP in the reaction mixture, act both as NMP-donors and NMP-acceptors yielding dAppppdA (22) Plateau & Blanquet, 1982; Günther Sillero et al., 1991; Pietrowska-Borek et al., 2003) and ddAppppddA (23) (Günther Sillero et al., 1997) , respectively. As mentioned previously, Ap 4 U can be also formed by yeast UTP:glucose-1-phosphate uridylyltransferase, which catalyzes transfer of UMP from UDP-glucose to ATP (Guranowski et al., 2004) . Another family of enzymatically produced Ap 4 A analogs, such as Ap 4 ddA or Gp 4 ddA, can be formed by HIV-1 reverse transcriptase (Meyer et al., 1998) . In pyrophosphorolysis-like reactions, this transferase carries out nucleotide-dependent removal of a dideoxynucleotide residue from the 3¢ -end of a chain-terminated DNA primer through production of a dinucleoside polyphosphate.
Other Ap 4 A derivatives modified on the sugar moiety can be obtained from reactions supported by 2¢ ,5¢ -poly(A) synthase, which introduces (deoxy)adenylate residue(s) onto the 2¢ -(and 2¢ ¢ ¢ -) position(s) of Ap 4 A (27) (Cayley & Kerr, 1982; Guranowski et al., 2000) while the recently reported poly(A) polymerase from E. coli can monoadenylate Ap 4 A at one of its two 3¢ -positions (28) (Günther Sillero et al., 2001; Guranowski et al., 2003) .
The adenine-containing analogs can be successively converted into their hypoxanthine-containing counterparts, Ip n Ns, such as Ip 4 A (16) and Ip 4 I by treatment with adenosine-phosphate deaminase (EC 3.5.4.17) from the snail Helix pomatia or the fungus Aspergillus oryzae (Guranowski et al., 1995) .
Finally, truncated Ap 4 A derivatives, such as adenosine(5¢ )tetraphospho(5¢ )ribose and ribose(5¢ )tetraphospho(5¢ )ribose, can be produced by ATP N-glycosidase from the marine sponge Axilla polypoides. This unusual enzyme catalyzes hydrolysis of the N-glycosidic bond in any compound containing an adenosine-5¢ -diphosphoryl moiety (Reintamm et al., 2003 Baril et al., 1983) or purchased from radiochemical suppliers Guranowski & Blanquet, 1985; Guranowski et al., 1987) (Prescott & McLennan, 1990; Baxi et al., 1994) .
[b-32 P]8-N 3 -Ap 4 A was also synthesized by Chavan & Haley (1994) to study its interaction with acidic fibroblast growth factor. [ 32 P]pA) has recently been synthesized (Günther Sillero et al., 2001) and used to study the susceptibility of this new type of Ap 4 A derivative to enzymatic cleavage catalyzed by several specific Ap 4 A-and/or Ap 3 A-degrading enzymes (Guranowski et al., 2003a) . Studies of these two sets of Ap 4 A derivatives also showed that the (asymmetrical)Ap 4 A hydrolases tolerate a bulky substituent such as a nucleotide at the 2¢ or 3¢ position of their potential substrates. The (symmetrical)Ap 4 A hydrolase from E. coli also cleaved 3¢ -pA(Apppp)A (to ADP and ADP(3¢ -pA)) but the yeast Ap 4 A phosphorylase and Ap 3 A hydrolases did not recognize this compound as a substrate (Guranowski et al., 2003a) .
APPLICATION OF SOME OTHER Ap 4 A ANALOGS; THEIR INTERACTION WITH DIFFERENT PROTEINS Ap 4 A homologs
So far, Ap 5 A has been the most useful of the Ap 4 A homologs. Acting as a bisubstrate analog it strongly inhibits adenylate (EC 2.7.4.3) and adenosine (EC 2.7.1.20) kinases. The lowest K i values, around 30 nM, were estimated for the adenylate kinases from rabbit (Lienhard & Secemski, 1973) and pig skeletal muscle (Feldhaus et al., 1975) . Based on this, an Ap 5 A-Sepharose affinity resin was prepared and successfully used for the isolation of adenylate kinase from vertebrate muscle (Feldhaus et al., 1975) . Ap 6 A was a much poorer inhibitor, with K i values of 450 nM for the porcine adenylate kinase (Feldhaus et al., 1975) and 55 nM for the rabbit muscle enzyme (Bone et al., 1986b) . Co-crystallization of Ap 5 A with adenylate kinases from pig muscle (Pai et al., 1977) , baker's yeast (Egner et al., 1987) and E. coli (Müller & Schulz, 1988) has allowed the three-dimensional structures of these enzymes to be studied. The K i values for Ap 5 A acting as a competitive inhibitor of MgATP binding were 73 nM and 400 nM, respectively, for the adenosine kinase from human liver (Bone et al., 1986b) and bovine adrenal me-dulla (Rotllan & Miras-Portugal, 1985) . Ap 5 A and Ap 6 A also inhibited calf thymus terminal deoxynucleotidyl transferase (EC 2.7.7.31) with K i values of 1.5 mM and 1.3 mM, respectively. These two compounds were found to be more effective than the diadenosine polyphosphates containing 2-, 3-or 4-phosphate groups. However, only Ap 5 A seems to span both the substrate and primer binding site domains of the enzyme . Ap 5 A and Ap 6 A also inhibit the nucleotide-depleted mitochondrial F 1 -ATPase (EC 3.6.1.34) and have been employed in studies of the orientation of the catalytic and non-catalytic sites of this enzyme (Vogel & Cross, 1991) . Finally, Ap 5 A has been shown to inhibit carbamoyl phosphate synthetase (glutamine hydrolyzing) (EC 6.3.5.5), indicating that this enzyme has two separate binding sites for ATP (Powers et al., 1977) . Ap 5 A and Ap 6 A also affect some physiological processes. Of the various Ap 2-6 As studied, Ap 5 A appeared to be the strongest inhibitor of ADP-induced human platelet aggregation (Harrison et al., 1977) while both Ap 5 A and Ap 6 A, which occur naturally in platelets, act as vasopressors (Schlüter et al., 1994) .
Another naturally occurring homolog of Ap 4 A, Ap 3 A, is the preferred Np n N substrate for various dinucleoside triphosphatases (EC 3.6.1.29) (Lobatón et al., 1975; Barnes et al., 1996; Guranowski et al., 1996) . These specific hydrolases always liberate AMP (NMP) from their substrates. In addition to Ap 3 A, they hydrolyze Ap 4 A (to AMP and ATP) and Ap 5 A, which is slowly degraded to AMP and p 4 A (Jakubowski Brevet et al., 1991; Prescott et al., 1992; Barnes et al., 1996) .
Hybrid analogs
Hybrid dinucleoside tetraphosphates, Ap 4 Ns (where N A), have been tested as alternative substrates for different Ap 4 A-degrading enzymes Plateau et al., 1985; Brevet et al., 1987; Prescott et al., 1989) and for Ap 3 A hydrolase (Barnes et al., 1996) . Their use has revealed the asymmetry of the Np 4 N¢ -binding sites of such enzymes as yeast Ap 4 A phosphorylase , asymmetrically acting Ap 4 A hydrolase from Artemia , and the human Fhit protein, which is a typical dinucleoside triphosphatase (Barnes et al., 1996) . In each case, a degree of preferential bond cleavage was observed for these hybrid molecules rather than random degradation. For example, phosphorolysis of Ap 4 G by yeast Ap 4 A phosphorylase yielded over 7-fold more ATP + GDP than GTP + ADP while hydrolysis of Ap 4 G by the Artemia Ap 4 A hydrolase yielded a 4.5-fold excess of AMP + GTP over GMP + ATP. The Fhit protein degraded Ap 4 G to AMP + GTP (85%) and GMP + ATP (15%). In addition, hybrid Ap 4 A analogs have been used as typical bisubstrate analogs in studies of various nucleoside and nucleotide kinases. Ap 4 U was shown to be an effective inhibitor of uridine kinase from Ehrlich ascites tumor cells (Cheng et al., 1986) and analogs with N = dN were used as probes for distinguishing between kinetic mechanisms of the appropriate kinases: Ap 4 dT for thymidine kinase (EC 2.7.1.21) (Bone et al., 1986a) , and Ap 4 dC, Ap 4 dG and Ap 4 dA for deoxycytidine (EC 2.7.1.74), deoxyguanosine (EC 2.7.1.113) and deoxyadenosine (EC 2.7.1.76) kinases (Ikeda et al., 1986) . Ap 4 dT, Ap 5 dT and Ap 6 dT were found to be inhibitors of thymidylate kinase (EC 2.7.4.9) from peripheral blast cells of patients with acute myelocytic leukemia (Bone et al., 1986b) and Ap 5 dT and/or P 1 -(5¢ -adenosyl)-P 5 -(5¢ ¢ ¢ -(3¢ ¢ -azido-3¢ ¢-deoxythymidine)pentaphosphate, AZT-p 5 A, were used in studies of the same kinase from yeast (Lavie et al., 1998a) and E. coli (Lavie et al., 1998b) . The crystal structures of the latter enzyme complexed with these compounds have been solved to 2.0-C and 2.2-C resolution. Davies and co-workers (1988) (Chavan & Haley, 1994) and sugarmodified analogs, dAp 4 dA and dAp 4 dT, were shown to be a new type of substrates for several DNA polymerases of human, bacterial and viral origin. The strongest activity of those compounds was observed for HIV reverse transcriptase (Victorova et al., 1999) .
Fluoro-and chromogenic analogs
eAp 4 A and eAp 4 eA (17) can serve as convenient fluorescent substrates of various Ap 4 A-degrading enzymes. Degradation of the latter results in a 6-fold increase in fluorescence intensity at 410 nm (Wierzchowski et al., 1985; Rotllán et al., 1991) . 5-Bromo-4-chloro-3-indolyl-tetraphospho-5¢-adenosine (19) was used as a chromogenic substrate for three different types of Ap 4 A-degrading enzymes in alkaline phosphatase-coupled reactions (Garrison et al., 1993) .
and P 1 -(lin-benzo-5¢-adenosyl)-P 4 -(5¢-adenosyl)tetraphosphate (18), both potent inhibitors of porcine muscle adenylate kinase, were used to study the active site of this enzyme. An increase in fluorescence intensities and fluorescence lifetimes of both inhibitors upon binding to adenylate kinase resulted from disruption of the intramolecular stacking interactions that prevail when these ligands are free in solution, suggesting that they bind to the enzyme in an "open" or "extended" form (VanDerLijn et al., 1979) .
Another fluorogenic analog, mAp 5 mA (26), was used to measure the binding constants of adenylate kinase-ligand complexes. It was specially designed for the E. coli enzyme, which has no tryptophan residues and therefore no strong intrinsic fluorescence signal to report ligand binding. Moreover, eAp 5 A produces no significant fluorescence enhancement with this enzyme, in contrast to mammalian cytosolic adenylate kinase. However, mAp 5 mA produced an exceptionally high fluorescence enhancement upon binding to E. coli adenylate kinase (about 300%) (Reinstein et al., 1990) .
Other Ap 4 A derivatives
Pyridoxal-tetraphospho-5¢-adenosine (21) has been used to explore the topography of the catalytic sites of the following enzymes. Acting as an affinity label it modified the active site of rabbit muscle lactate dehydrogenase (EC 1.1.1.27) (Tagaya & Fukui, 1986) and glutathione synthetase (EC 6.3.2.3) (Hibi et al., 1993) and inactivated rabbit muscle adenylate kinase (Yagami et al., 1988) and sheep brain pyridoxal kinase (Dominici et al., 1988) .
Diinosine polyphosphates (Ip n Is) have been shown to act as selective antagonists at a diadenosine polyphosphate receptor identified in rat brain synaptic terminals. The best was Ip 5 I, which was 6000-fold more selective for the P4 dinucleotide receptor than for the ATP receptor (Pintor et al., 1997) . Recently, Ip 5 I and Ip 6 I were proposed as valuable tools for diabetes research. They antagonize Ap 5 A-mediated inhibition of insulin release from insulin-secreting (INS-1) cells (Verspohl et al., 2003) . A. Guranowskizymes, acting as substrates and/or potent inhibitors. Chronologically, the first were AppCH 2 ppA (2), AppCHBrppA, ApCH 2 pppA (3) and ApCH 2 ppCH 2 pA (4) (Guranowski et al., 1987 (Guranowski et al., 1989) . McLennan and coworkers (1989) studied a set of 13 phosphonate Ap 4 A analogs with the (asymmetrical)Ap 4 A hydrolase from Artemia and established that the substrate efficiency of bb' -substituted compounds decreased with decreasing substituent electronegativity (O>CF 2 >CFH>CCl 2 >CClH>CH 2 ). These compounds were competitive inhibitors of this enzyme with K i values that generally also decreased with electronegativity from 12 mM for AppCF 2 ppA to 0.4 mM for AppCH 2 ppA (K m for Ap 4 A was 33 mM). Disubstituted analogs were generally less effective inhibitors. However, they displayed a low and unexpected rate of symmetrical cleavage by the Artemia enzyme. Both sets of analogs were also competitive inhibitors of E. coli Ap 4 A hydrolase with K i values ranging from 7 mM for App-CH 2 ppA to 250 mM for ApCH 2 CH 2 pp-CH 2 CH 2 pA. The only disubstituted analog to be hydrolyzed by the E. coli enzyme was ApCF 2 ppCF 2 pA at 0.2% of the rate of Ap 4 A; however, several of the bb¢-substituted compounds showed a limited degree of asymmetrical cleavage. These results were interpreted in terms of a "frameshift" model for substrate binding in which the oligophosphate chain can position itself in the active site of the enzyme with either P a or P b adjacent to the attacking nucleophile (water) depending on the electronegativity of the substituent. Due to their ability to bind tightly to Ap 4 A hydrolases, some of the methylene and halomethylene analogs were used to determine the three-dimensional structures of the enzyme-substrate complexes: a non-degradable analog with two types of modification, Ap s pCHClpp s A (9), was complexed with the enzyme from Lupinus angustifolius (Swarbrick et al., 2000) and AppCH 2 ppA with the hydrolase from Caenorhabditis elegans (Bailey et al., 2002) . In physiological assays with INS-1 cells, Ap s pCH 2 pp s A and Ap s pCHClpp s A inhibited insulin release to the same degree as Ap 4 A (Verspohl et al., 2003) . AppCH 2 ppA, AppCHFppA and AppCHClppA were quite potent inhibitors of rat brain adenosine kinase while AppCCl 2 ppA was approximately 5-times less potent (Delaney et al., 1997) . Different methylene and halomethylene analogs of Ap 4 A, eAp 4 A, eAp 4 eA, as well as an imido-analog (AppNHppA) were examined as effectors of the ADP-ribosylation reaction of histone H1 catalyzed by purified bovine thymus poly(ADP-ribose)transferase (EC 2.4.2.30 ). Of the compounds tested, ApCH 2 pppA and eAp 4 A were shown to be the most effective inhibitors of the enzyme. The imido analog was the least effective (Suzuki et al., 1987) . To the best of my knowledge, there are no other reports of effects exerted by the imido analog. Vol. 50 Ap 4 A analogs 961
The monophosphorothioates (S p )Ap 4 AaS (6) and (R p )Ap 4 AaS (7) were tested as alternative substrates for three specific Ap 4 A-degrading enzymes (£a¿ewska & Guranowski, 1990) ; the asymmetrically degrading Ap 4 A hydrolase from yellow lupin seeds, symmetrically acting Ap 4 A hydrolase from E. coli and the Ap 4 A phosphorylase from yeast. Generally, the R p isomer was a better substrate for all three enzymes than the S p one. Interestingly, the S p analog was cleaved randomly by the yeast phosphorylase yielding four reaction products: ATP, ATPaS, ADP and ADPaS. Since the latter product retained its configuration at the a-phosphorus, this confirmed formation of a covalent NMP-enzyme intermediate as previously postulated (Guranowski et al., 1988 (Guranowski et al., 1994) (Blackburn et al., 1987b ). Another Ap 4 A analog with dual modifications, Ap s pCHClpp s A (9), proved to be a promising anti-platelet aggregation agent (Chen et al., 1997) .
Recently, strong inhibition of ADP-triggered blood platelet aggregation was also reported for the analog containing a central di(hydroxymethyl)phosphonic acid moiety in which both non-bridging oxygens of the phosphates linked directly to each terminal adenosyl residue were replaced with sulfur atoms (compound 15) (Walkowiak et al., 2002) .
Adenylated derivatives of methanetrisphosphonate, so called "supercharged" analogs of Ap 4 A, have been shown to be effective inhibitors of Ap 3 A hydrolases . They were, however, poor inhibitors of the human and narrow-leafed lupin (asymmetrical)Ap 4 A hydrolases (Maksel et al., 1999) ; only the triadenylated compound, App-CH-(ppA)-ppA (10), exerted a significant effect, with IC 50 values estimated in the presence of 50 mM Ap 4 A of 80 mM for the human and 40 mM for the lupin enzyme. A novel family of Ap 4 A analogs in which adenylate or adenosine-5'-phosphorothioate residues are chemically attached to polyols such as glycerol, erythritol and pentaerythritol (Baraniak et al., 1999) have been tested in my laboratory as potential substrates and/or inhibitors of the following enzymes: Ap 3 A hydrolase from yellow lupin seeds, human Ap 3 A hydrolase (Fhit protein), yeast Ap 4 A phosphorylase, (symmetrical)Ap 4 A hydrolase from E. coli and two (asymmetrical)Ap 4 A hydrolases, from narrow-leafed lupin and humans. All the compounds were resistant to the action of these enzymes. However, as inhibitors, they behaved differently. Generally, the adenosine-5'-O-phosphorothioylated polyols were much more potent inhibitors of these enzymes than their adenosine-5'-O-phosphorylated counterparts. Yeast Ap 4 A phosphorylase was the most refractory to inhibition. The Ap 3 A hydrolases were inhibited quite effectively but the estimated K i values did not exceed the range of K m s for Ap 3 A; i.e. they were not lower than 10 -6 M. The strongest inhibitory effects were observed for some of these analogs with the Ap 4 A hydrolases (Guranowski et al., 2003b) , -showed that each enzyme was inhibited to a different extent, probably due to small differences in the shape (topography) of the active sites of these hydrolases. Interestingly, the homologous compound di(adenosine-5¢-O-phosphorothio)glycerol was not inhibitory. To further pursue this structure-activity relationship, two di(adenosine-5'-O-phosphorothio)diols, 1,4-di(adenosine-5'-O-phosphorothio)butanediol and 1,5-di(adenosine-5'-O-phosphorothio)pentanediol, were synthesized. These two compounds inhibited neither the lupin nor the human (asymmetrical)Ap 4 A hydrolase. Thus, one can conclude that not only the distance between the adenosine-5'-O-phosphorothio-residues matters but also the presence of hydroxyls in the chain linking the two nucleosides. The strongest inhibitors of the (symmetrical)Ap 4 A hydrolase from E. coli were also the strongest when tested with the equivalent symmetrically acting enzyme from Salmonella typhimurium, although the K i values for the latter enzyme were markedly higher from those found for the E. coli counterpart: 0.2 mM versus 0.04 mM for di(adenosine-5'-O-phosphorothio), di(phosphorothio)pentaerythritol and 1.7 mM versus 0.08 mM for tri(adenosine-5'-O-phosphorothio), phosphorothio-pentaerythritol. This result also points to small differences in the binding sites of these two similar enzymes.
Of the enzymes that specifically hydrolyze dinucleoside tri-or tetraphosphates, only the (symmetrical)Ap 4 A hydrolase has not yet had its three-dimensional structure determined. The above analogs may help this goal to be achieved.
CONCLUDING REMARKS AND PERSPECTIVES
As has been shown in this review, Ap 4 A analogs helped to increase our knowledge about the enzymes involved in the metabolism of Ap 4 A and other nucleotides. In particular, the hybrid analogs, Ap 4 Ns, proved to be alternative substrates of different Ap 4 A-degrading enzymes. The preference of cleavage of these asymmetrical compounds as well as other asymmetrically modified Ap 4 A derivatives, e.g. 2'-or 3'-adenylylated Ap 4 As, showed that the active sites of the Ap 4 A hydrolases and Ap 4 A phosphorylases are also asymmetric. Various Ap 4 Ns and an Ap 4 A homolog, Ap 5 A, were applied as useful tools in studies of different nucleoside and/or nucleotide kinases. Ap 4 A analogs modified in the oligophosphate chain, particularly the non-degradable ones, such as AppCH 2 ppA and Ap s pCHClpp s A, form stable complexes with (asymmetrical)Ap 4 A hydrolases and this allowed the determination of the three-dimensional structures of these enzymes from the nematode C. elegans (Bailey et al., 2002) and higher plant L. angustifolius (Swarbrick et al., 2000) , respectively. The very strong inhibition of (symmetrical)Ap 4 A hydrolases by some adenylylated and adenosine-5'-phosphorothioated polyols (Guranowski et al., 2003b) encourages one to use these analogs for determination of the three-dimensional structure of a (symmetrical)Ap 4 A hydrolase. metrical)Ap 4 A hydrolase (Dixon & Lowe, 1989) and Ap 4 A phosphorylase (Łażewska a& ) to be elucidated. The extracellular, physiological effects of Ap n As (Lüthje & Ogilvie, 1988; Miras-Portugal et al., 1999; Campbell et al., 1999; Hoyle et al., 2001) call for more detailed studies on the interaction of these compounds with purine-nucleoside receptors (P1), purine-mononucleotide receptors (P2X, P2Y) and specific receptors termed dinucleotide or P4 receptors, and on the enzymes located on the cell surface, such as ecto-nucleotide pyrophosphatases/phosphodiesterases, NPP1, NPP2 and NPP3 (Vollmeyer et al., 2003) . Ap 4 A analogs should help to discriminate between these proteins and to better understand the role of Ap 4 A and other Np n N's as signal molecules. Finally, I anticipate studies on new Ap n A-derivatives, adenosine(5')polyphospho(5')riboses and ribose(5')polyphospho(5')riboses, that can be produced by the use of a novel enzyme, ATP N-glycosidase (Reintamm et al., 2003) . Testing of these truncated Ap 4 A derivatives as potential substrates and/or inhibitors of different Ap 4 A-degrading enzymes will shed new light on the requirements of those enzymes with respect to the structure of their substrates.
964
A. Guranowski 2003 
